Order Online! Now! Get your $50 coupon for online order.Order Online! Now! Get your $50 coupon for online order.
Cancer Prevention Month: Get ACRO Health Gift Cards! Cancer Prevention Month: Get ACRO Health Gift Cards!
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Fill out organ-on-a-chip questionnaire to win a FREE gift! Fill out organ-on-a-chip questionnaire to win a FREE gift!
Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
IL5 mAb | Monospecific antibody | Immunological disease | Asthma | Phase II | Global (except China) |
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
EP-128 | Human | IL-5[Biotinylated]:IL-5Rα Inhibitor Screening ELISA Kit | |||
IL5-C52H3 | Cynomolgus | Cynomolgus IL-5 Protein, His Tag |
|
|
|
IL5-M52H3 | Mouse | Mouse IL-5 Protein, His Tag (MALS verified) |
|
|
|
IL5-R52H4 | Rabbit | Rabbit IL-5 Protein, His Tag |
|
|
|
IL5-H82Q5 | Human | Biotinylated Human IL-5 Protein, His,Avitag™ |
|
|
|
IL5-H52H3 | Human | Human IL-5 Protein, His Tag, premium grade |
|
|
Loaded Human IL-5, His Tag, premium grade (Cat. No. IL5-H52H3) on NTA Biosensor, can bind Human IL-5 R alpha, Fc Tag with an affinity constant of 4.63 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Mepolizumab | 240563; SB-240563 | Approved | Glaxosmithkline Plc | Bosatria, Nucala, 美泊利珠单抗 | United States | Asthma | Glaxosmithkline Llc | 2015-11-04 | Eosinophilic Esophagitis; Dermatitis, Atopic; Angioedema; Fasciitis; Pulmonary Disease, Chronic Obstructive; Bronchitis; Eosinophilic Granuloma; Asthma; Sinusitis; Hypereosinophilic Syndrome; Virus Diseases; Nose Diseases; Chronic Urticaria; Eosinophilia; Nasal Polyps; Churg-Strauss Syndrome; Granulomatosis with Polyangiitis | Details |
Reslizumab | TRFK-5; CDP-835; SCH-5570; CEP-38072; CTx-55700; SCH-55700 | Approved | Teva Pharmaceutical Industries Ltd | Cinqair, Cinquil, Cinqaero | United States | Asthma | Teva Respiratory Llc | 2016-03-23 | Hypereosinophilic Syndrome; Loiasis; Pulmonary Eosinophilia; Eosinophilic Esophagitis; Asthma; Bronchitis | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
long-acting anti-IL-5 mAb (GSK) | Phase 1 Clinical | Glaxosmithkline Plc | Asthma | Details | |
KBL-693 | KBL-693 | Phase 1 Clinical | Kobiolabs | Asthma | Details |
Mepolizumab biosimilar(Bio Thera Solutions) | BAT2606; BAT-2606 | Phase 1 Clinical | Bio-Thera Solutions Ltd | Nasal Polyps; Autoimmune Diseases; Sinusitis; Asthma | Details |
Recombinant anti-IL-5 humanized monoclonal antibody (Shanghai CP Guojian) | 610 | Phase 2 Clinical | Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd | Autoimmune Diseases; Asthma | Details |
SHR-1703 | SHR-1703 | Phase 3 Clinical | Suzhou Suncadia Biopharmaceuticals Co Ltd, Jiangsu Hengrui Medicine Co Ltd, Shanghai Hengrui Pharmaceutical Co Ltd | Granulomatosis with Polyangiitis; Churg-Strauss Syndrome; Asthma | Details |
Mepolizumab biosimilar (CTTQ Pharma) | Phase 1 Clinical | Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group | Granulomatosis with Polyangiitis; Hypereosinophilic Syndrome; Vasculitis; Nasal Polyps; Asthma; Eosinophilic Granuloma; Sinusitis; Lymphohistiocytosis, Hemophagocytic | Details | |
RC-1416 | Phase 1 Clinical | Nanjing Rongjiekang Biotechnology Co Ltd | Asthma | Details | |
Depemokimab | GSK-294; GSK3511294; GSK294; GSK-3511294 | Phase 3 Clinical | Glaxosmithkline Plc | Hypereosinophilic Syndrome; Churg-Strauss Syndrome; Nasal Polyps; Vasculitis; Asthma; Eosinophilic Granuloma; Sinusitis | Details |
This web search service is supported by Google Inc.